Siemens Healthineers has recently received FDA clearance for a new cardiovascular ultrasound system called the ACUSON Origin. This system, powered by artificial intelligence (AI), is designed to make heart procedures more efficient and accurate. It’s a development that could have a significant impact on how doctors diagnose and treat heart conditions.
A notable feature of the ACUSON Origin is the AcuNav Lumos 4D ICE catheter, which provides detailed imaging for complex heart procedures. This catheter is particularly useful for patients who can’t undergo traditional heart interventions due to issues with anesthesia or other contraindications.
According to David Zollinger, head of Cardiovascular Ultrasound at Siemens Healthineers, the new system has the potential to improve patient care by enhancing the accuracy of diagnoses and making procedures more efficient.
The ACUSON Origin is designed to assist with a wide range of heart-related procedures, including those in structural heart disease, vascular issues, electrophysiology, and pediatric care. Its AI features help reduce the workload for doctors, making exams more consistent and efficient. The system uses AI to automate tasks like measurements and view recognition, which can speed up the process and improve accuracy.
One of the system’s key innovations is its ability to recognize different views of the heart in real-time, something that’s a first for ultrasound technology. This feature, called AI Assist, helps doctors quickly identify and focus on the right areas during an exam, with a 99% accuracy rate in placing the necessary Doppler measurements.
The ACUSON Origin also includes tools for automatically measuring and tracking the heart’s chambers, both in 2D and 4D, without needing an electrocardiogram (ECG). These features are highly accurate and help streamline the process of assessing heart function.
The AcuNav Lumos catheter enhances the guidance of procedures by offering more detailed imaging and real-time 4D color Doppler, which helps doctors make more precise assessments during heart interventions. This is particularly beneficial for treating conditions like tricuspid regurgitation in patients who might not tolerate traditional imaging methods.
Overall, the ACUSON Origin system and the AcuNav Lumos catheter represent significant advancements in heart care technology, offering new ways to improve the accuracy and efficiency of cardiovascular procedures. These tools are expected to be valuable in helping doctors provide better care for their patients during a variety of heart procedures.